Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HLX04 vs bevacizumab in metastatic colorectal cancer
CTR20171503Phase 3Completed
- Sponsor
- Henlius
- Start
- Mar 2018
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of HLX04-O in metastatic colon cancer (mCRC), colorectal adenocarcinoma (mCRC), sponsored by Henlius. Started Mar 2018; status: completed.
02
Drugs
HLX04-O
03
Conditions
metastatic colon cancer (mCRC)colorectal adenocarcinoma (mCRC)
Beyond the preview
Go deeper on CTR20171503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20171503.